Reference
Institute for Clinical and Economic Review. ICER's Assessment Highlights the Risk-Benefit Tradeoffs of Investigational Treatments for Peanut Allergy. Internet Document : 28 May 2019. Available from: URL: https://icer-review.org/announcements/peanut_evidence_report/
Rights and permissions
About this article
Cite this article
ICER to nut out the benefits of allergy treatments. PharmacoEcon Outcomes News 830, 1 (2019). https://doi.org/10.1007/s40274-019-5952-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5952-0